Noticias de EDSA_US

Noticias del mercado

Últimas noticias sobre EDSA_US — 41 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: EDSA_US ✕ 41 resultados
08/03/2026 EDSA_US — StocksToTrade
Edesa Biotech’s Paridiprubart Trial Success Spurs Market Optimism
08/03/2026 EDSA_US — timothysykes.com
Edesa Biotech Gains Ground with Positive Clinical and Financial News
07/03/2026 EDSA_US — timothysykes.com
Edesa Biotech Advances on Promising Drug Trial Results
04/03/2026 EDSA_US — Benzinga
Why Box Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket - Arbutus Biopharma (NA
03/03/2026 EDSA_US — Stock Titan
Point72 group (NASDAQ: EDSA) reports 600,000 shares, 7.2% stake
02/03/2026 EDSA_US — Stock Titan
Velan Capital details Edesa Biotech (NASDAQ: EDSA) 9.99% stake
02/03/2026 EDSA_US — Stock Titan
Edesa Biotech (NASDAQ: EDSA) CEO adds 50,571 shares in open-market buys
02/03/2026 EDSA_US — Yahoo Finance
EDSA: Strengthened Phase 3 ARDS Data Shows Significant Reduction in 28-Day Mortality
01/03/2026 EDSA_US — StocksToTrade
Edesa Biotech Advances with Promising Phase 3 Outcomes
28/02/2026 EDSA_US — StocksToTrade
Edesa Biotech’s Strategic Advances Boost Stock Outlook
28/02/2026 EDSA_US — timothysykes.com
Edesa Biotech Surpasses Expectations with Promising Phase 3 Data
24/02/2026 EDSA_US — GlobeNewswire
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study
24/02/2026 EDSA_US — Stock Titan
Edesa drug cuts death risk to 24% in Phase 3 ARDS trial
24/02/2026 EDSA_US — Investing.com
Edesa Biotech stock surges on positive Phase 3 trial data
24/02/2026 EDSA_US — Investing.com
Edesa Biotech reports mortality reduction in phase 3 trial
24/02/2026 EDSA_US — Investorideas.com
Biotech Stock Edesa Biotech (Nasdaq:EDSA) Gains on News of Additional Positive Results from Phase 3 Paridiprubart Study
24/02/2026 EDSA_US — TipRanks
Edesa Biotech Reports Positive Phase 3 Paridiprubart Results
18/02/2026 EDSA_US — Intellectia AI
EDSA Should I Buy
13/02/2026 EDSA_US — Quiver Quantitative
Edesa Biotech, Inc. Reports Q1 2026 Financial Results and Updates on Clinical Programs for EB06 and Paridiprubart
13/02/2026 EDSA_US — TradingView
Edesa Biotech, Inc. SEC 10-Q Report

Página 2 de 3

keyboard_arrow_up